Marie Egan

Professor

Yale University
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (2)

In utero gene editing has the potential to modify disease causing genes in multiple developing tissues before birth, possibly allowing for normal organ development, disease improvement, and conceivably, cure. In cystic fibrosis (CF), a disease that arises from mutations in the cystic fibrosis transmembrane conductance regulator ( CFTR ) gene, there are signs of multiorgan disease affecting the function of the respiratory, gastrointestinal, and reproductive systems already present at birth. Thus, treating CF patients early is crucial for preventing or delaying irreversible organ damage. Here we demonstrate proof-of-concept of multiorgan mutation correction in CF using peptide nucleic acids (PNAs) encapsulated in polymeric nanoparticles and delivered systemically in utero. In utero editing was associated with sustained postnatal CFTR activity, at a level similar to that of wild-type mice, in both respiratory and gastrointestinal tissue, without detection of off-target mutations in partially homologous loci. This work suggests that systemic in utero gene editing represents a viable strategy for treating monogenic diseases before birth that impact multiple tissue types.

Year:

2024

IgE antibodies against the allergen Ara-h2 can cause life-threatening anaphylaxis upon exposure to peanuts. Desensitization strategies aim at inducing IgG responses against Ara-h2 which may compete with anaphylactogenic IgE. Here we assessed anti-Ara-h2 titers in an unselected cohort of 24,536 adult patients admitted to a general hospital for disparate medical reasons. Surprisingly, adult (n=177) and pediatric (n=76) patients with cystic fibrosis (pwCF) had IgG4, but not IgE, against several peanut and soybean allergens, yet did not suffer from peanut allergy. Antibody repertoires were not globally perturbed in pwCF, and heterozygous Cystic Fibrosis Transmembrane Regulator ( CFTR ) mutation carriers had the same prevalence of food allergies as pwCF. Peanut sensitisation of Cftr -/- mice failed to induce IgE and was associated with elevated IFN-γ. We conclude that CFTR is a key regulator of anaphylactogenic and tolerogenic responses to food allergens. CFTR-controlled cytokine responses including IFN-γ, in combination with a compromised epithelial barrier, may trigger a preferential IgG4 response resulting in tolerance to food allergens. Highlights We investigated serum IgG against Ara-h2 in 24,536 patients and identified 133 seropositives. Seropositivity was associated with cystic fibrosis, and these patients had IgG4 but not IgE. We reproduced these results in a paediatric validation cohort and in a Cftr -/- mouse model. A compromised epithelial barrier and the cytokine milieu might explain this phenotype.

Year:

2024

Collaborators (12)

Tuomas Knowles

1920 Professor of Physical Chemistry

University of Cambridge

UNITED KINGDOM
View details

Adriano Aguzzi

-

SWITZERLAND
View details

W. Mark Saltzman

Professor

Yale University

UNITED STATES
View details

Anisha Gupta

Assistant Professor

University of Saint Joseph School of Pharmacy

UNITED STATES
View details

Stephanie C. Eisenbarth

Professor

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Alexandra Piotrowski-Daspit

Assistant Professor

University of Michigan

UNITED STATES
View details

Georg Meisl

Assistant Research Professor

University of Cambridge

UNITED KINGDOM
View details

Hubert Rehrauer

University of Zurich

SWITZERLAND
View details

Stephanie Leeds

Assistant Professor

Yale University School of Medicine

UNITED STATES
View details

Aaron Ring

Associate Professor

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Roland Martin

University of Zurich

SWITZERLAND
View details

Peter Glazer

Professor and Chair

Yale University

UNITED STATES
View details